SCHEMBL20809657

SCHEMBL20809657

CSC(=O)c1ccccn1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.61
CES2 O00748 1/20 0.59
CES1 P23141 1/20 0.59
L3MBTL1 Q9Y468 2/20 0.57
LMNA P02545 2/20 0.57
NAPRT Q6XQN6 1/20 0.57
P4HTM Q9NXG6 1/20 0.57
KMT2A Q03164 3/20 0.52
GSK3B P49841 1/20 0.50
RAB9A P51151 4/20 0.47
SMN1; SMN2 Q16637 4/20 0.47
NPC1 O15118 3/20 0.47
GRM4 Q14833 2/20 0.47
PKM P14618 2/20 0.47
MAPT P10636 1/20 0.47
KDM4E B2RXH2 4/20 0.47
HTT P42858 1/20 0.46
GAA P10253 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
MEN1 O00255 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27521214 0.79 CES2 (0.59) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL19543224 0.79 ALDH1A1 (0.55) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL27039751 0.77 CES2 (0.62) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL29601190 0.77 KMT2A (0.55) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL11051347 0.77 KMT2A (0.55) ALDH1A1CES2CES1L3MBTL1LMNA
Methylsulfanylmethane SCHEMBL28249594 0.76 ALDH1A1 (0.57) ALDH1A1CES2CES1L3MBTL1LMNA
SCHEMBL55127 0.76
SCHEMBL11809728 0.76
SCHEMBL29358072 0.76
Methyl Alcohol SCHEMBL27687010 0.76 ALDH1A1 (1.00) ALDH1A1CES2CES1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11046670-B2 Piperazinyl norbenzomorphan compounds and methods for using the same BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2021-06-29 US disclosed
CN-106660958-B The manufacturing method of 3- (alkyl sulphonyl) pyridine-2-carboxylic acids 住友化学株式会社 2019-04-12 CN disclosed
US-20190077789-A1 PIPERAZINYL NORBENZOMORPHAN COMPOUNDS AND METHODS FOR USING THE SAME BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2019-03-14 US disclosed
CN-106660958-A Method for manufacturing 3-(alkyl sulfonyl)pyridine-2-carboxylic acid 住友化学株式会社 2017-05-10 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190077789-A1 PIPERAZINYL NORBENZOMORPHAN COMPOUNDS AND METHODS FOR USING THE SAME GAP43, NCDN, NLN ALDH1A1 1985/4885CES2 1214/4885CES1 2129/4885
US-11046670-B2 Piperazinyl norbenzomorphan compounds and methods for using the same GAP43, NCDN, NLN ALDH1A1 1985/4885CES2 1214/4885CES1 2129/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.